Biosynex: return to growth, share price rises

(CercleFinance.com) - Biosynex, a manufacturer of rapid diagnostic tests, is shining on the stock market this Friday after announcing a return to growth in the first half of the year.


The group reports that it generated sales of 53.8 million euros in the first six months of the year, up 26% on the same period last year.

On a like-for-like basis, growth reached 6%.

In a press release, Biosynex explains that its business has resumed an upward trajectory thanks to the contribution of its latest strategic acquisitions and the good sales trend for its organic products.

The company adds that the share of sales generated by its American subsidiaries now represents 22%, a share deemed "significant" in the assessment of its overall performance.

The company adds that it intends to continue to gain strength in this strategic geographic zone by reinforcing its commercial activity in the United States.

Lastly, the laboratory indicated that it was continuing discussions with its banking pool in order to restructure its debt.

At mid-day, the share price was up by more than 22% in the wake of this half-yearly publication.

Copyright (c) 2024 CercleFinance.com. All rights reserved.